Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
Afatinib reverses ceritinib resistance (CR) in ALK/ROS1-positive non-small-cell lung cancer cell (NSCLC) via suppression of NRG1 pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,374 | Dovepress* | 8,349+ | 790 | 9,139 | |
| PubMed Central* | 1,025 | 258 | 1,283 | ||
| Totals | 9,374 | 1,048 | 10,422 | ||
| *Since 26 November 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 1 | 2 | 3 |
View citations on PubMed Central and Google Scholar